Journal of Clinical Research and Healthcare

Aim

The Journal of Clinical Research and Healthcare (JCRH) aims to advance knowledge in clinical medicine, healthcare research, biomedical science, and health systems by providing an international platform for the communication of rigorous scholarly research.

The journal seeks to support research that improves understanding of human health and disease, advances diagnosis and treatment, strengthens healthcare practice and delivery, and contributes to improved patient and population health outcomes.

JCRH welcomes interdisciplinary research connecting clinical medicine with biomedical sciences, public health, healthcare technology, informatics, data science, and emerging approaches to healthcare. The journal serves clinicians, healthcare professionals, researchers, scientists, educators, and scholars across the health sciences.

Scope

JCRH considers original research, clinical studies, systematic and narrative reviews, case reports and case series, methodological studies, short communications, perspectives, and other scholarly contributions that fall within the journal's scientific and clinical remit. The scope includes, but is not limited to:

Clinical Medicine and Patient Care

• General and internal medicine; family and primary care.
• Cardiology and cardiovascular medicine; neurology and neuroscience.
• Oncology and cancer research; endocrinology and metabolic disorders.
• Gastroenterology and hepatology; pulmonology and respiratory medicine.
• Nephrology and renal medicine; dermatology; rheumatology and musculoskeletal medicine.
• Infectious diseases; pediatrics and adolescent health; geriatrics.
• Obstetrics, gynecology, and women's health.
• Emergency and critical care; surgery and perioperative care.
• Rehabilitation and physical medicine; mental and behavioral health; nutrition and clinical nutrition.

Clinical and Translational Research

• Clinical trials, intervention studies, observational research, and comparative clinical studies.
• Evidence-based medicine, clinical decision-making, and clinical practice research.
• Translational medicine and research connecting laboratory findings with clinical applications.
• Biomarkers, precision medicine, personalized medicine, and disease-risk assessment.
• Therapeutic development, clinical pharmacology, pharmacology, and pharmacovigilance.
• Clinical outcomes, treatment effectiveness, patient-reported outcomes, and quality-of-care research.

Biomedical and Diagnostic Sciences

• Molecular and cellular biology, physiology, biochemistry, genetics, genomics, and immunology.
• Microbiology, virology, pathology, toxicology, and related biomedical sciences.
• Laboratory medicine, clinical pathology, molecular diagnostics, and diagnostic test evaluation.
• Medical imaging and diagnostic technologies.
• Biomedical engineering, medical devices, biomaterials, biotechnology, and regenerative medicine.

Public Health and Population Health

• Public health, epidemiology, global health, and population health.
• Health promotion, disease prevention, screening, surveillance, and community health.
• Health disparities, health equity, and social determinants of health.
• Environmental and occupational health.
• Health policy, health systems, health services research, and healthcare access.

Healthcare Practice, Quality, and Education

• Nursing, allied health, and multidisciplinary healthcare practice.
• Patient safety, healthcare quality improvement, and clinical governance.
• Healthcare management, administration, organization, and service delivery.
• Patient-centered care and shared decision-making.
• Medical education, healthcare education, clinical training, and professional development.

Digital and Emerging Healthcare

• Digital health, telemedicine, telehealth, and connected healthcare.
• Health informatics, biomedical informatics, electronic health records, and clinical information systems.
• Artificial intelligence and machine learning in healthcare and clinical research.
• Clinical decision-support systems, remote patient monitoring, and wearable health technologies.
• Biomedical data science, computational medicine, and data-driven healthcare.

Manuscript Types

• Original Research Articles
• Review Articles and Systematic Reviews
• Case Reports / Case Series, where appropriate
• Short Communications and Technical Articles
• Editorials, Commentaries, Perspectives and Letters

Manuscript Preparation

• Manuscripts must be original, unpublished and not under consideration elsewhere.
• Submit in clear English and ensure the work fits the selected journal's Aim and Scope.
• Include: Title Page, Abstract, Keywords, Introduction, Methods, Results, Discussion, Conclusion and References, as applicable.
• Title page should include author names, affiliations, corresponding-author details and 3–8 keywords.
• Abstract: maximum 250 words, summarizing the objective, methods, main findings and conclusion.
• Tables and figures must be numbered, titled, cited in the text and supplied in suitable quality.
• References should be complete and consistently formatted according to the journal's requirements.

Submission & Peer Review

• Submit through the official AJEN submission system or submission route stated on the journal website.
• A brief cover letter should identify the article type, originality and significance.
• Each submission undergoes an initial editorial assessment before external review.
• AJEN's standard review model is single-blind peer review; reviewers' identities are not normally disclosed to authors.
• Editors may request revisions. Acceptance is based on editorial assessment and peer-review recommendations.

Research Ethics

• Human and animal research must comply with applicable ethical requirements and include approval/consent information where required.
• Authors must disclose funding and relevant conflicts of interest.
• Plagiarism, duplicate publication, fabricated/falsified data and misleading image manipulation are unacceptable.
• Material use of generative AI or AI-assisted tools should be disclosed; AI tools cannot be listed as authors.

Publication Charges

Payment: The APC is due only after acceptance. Payment does not influence the editorial decision or guarantee publication. If an author requests withdrawal after peer review has commenced or after substantial editorial/production work, a manuscript withdrawal charge of €499 may apply. AJEN may consider full or partial APC waivers in cases of genuine financial need.

After Acceptance

• Accepted manuscripts proceed to production and publication.
• Authors receive proofs for final checking and should return corrections promptly.
• Published articles are freely accessible under AJEN's applicable open-access terms.